際際滷

際際滷Share a Scribd company logo
SHOCK MANAGEMENT
PRESENTATION
BY
DR AMINU BELLO
DIRECTOR SCHOOL OF
NURSING KATSINA
Shock
 Syndrome characterized by decreased tissue
perfusion and impaired cellular metabolism
 Imbalance in supply/demand for O2 and nutrients
Shock (Contd)
 Classification of shock
 Low blood flow
 Cardiogenic
 Hypovolemic
 Maldistribution of blood flow
 Septic
 Anaphylactic
 Neurogenic
Low Blood Flow
Carcinogenic Shock
 Definition
 Systolic or diastolic dysfunction
 Compromised cardiac output (CO)
Low Blood Flow
Cardiogenic Shock (Contd)
 Precipitating causes
 Myocardial infarction
 Cardiomyopathy
 Blunt cardiac injury
 Severe systemic or pulmonary hypertension
 Cardiac tamponade (Obstructive)
 Myocardial depression from metabolic problems
Pathophysiology of Cardiogenic Shock
Low Blood Flow
Cardiogenic Shock
 Early manifestations
 Tachycardia
 Hypotension
 Narrowed pulse pressure
  Myocardial O2 consumption
Low Blood Flow
Cardiogenic Shock (Contd)
 Physical examination
 Tachypnea, pulmonary congestion
 Pallor; cool, clammy skin
 Decreased capillary refill time
 Anxiety, confusion, agitation
  in pulmonary artery wedge pressure
 Decreased renal perfusion and UO
Low Blood Flow
Hypovolemic Shock
 Absolute hypovolemia: Loss of intravascular
fluid volume
 Hemorrhage
 GI loss (e.g., vomiting, diarrhea)
 Fistula drainage
 Diabetes insipidus
 Hyperglycemia
 Diuresis
Low Blood Flow
Hypovolemic Shock (Contd)
 Relative hypovolemia
 Results when fluid volume moves out of the
vascular space into extravascular space (e.g.,
interstitial or intracavitary space)
 Termed third spacing
Pathophysiology of Hypovolemic Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Low Blood Flow
Hypovolemic Shock
 Response to acute volume loss depends on
 Extent of injury or insult
 Age
 General state of health
Low Blood Flow
Hypovolemic Shock (Contd)
 Clinical manifestations
 Anxiety
 Tachypnea
 Increase in CO, heart rate
 Decrease in stroke volume, PAWP, UO
 If loss is >30%, blood volume is replaced
Maldistribution of Blood Flow
Neurogenic Shock
 Hemodynamic phenomenon that can occur
within 30 minutes of a spinal cord injury at the
fifth thoracic (T5) vertebra or above and can
last up to 6 weeks
 Results in massive vasodilation leading to
pooling of blood in vessels
Pathophysiology of Neurogenic Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Maldistribution of Blood Flow
Neurogenic Shock (Contd)
 Clinical manifestations
 Hypotension
 Bradycardia
 Temperature dysregulation (resulting in heat loss)
 Dry skin
 Poikilothermia (taking on the temperature of the
environment)
Maldistribution of Blood Flow
Anaphylactic Shock
 Acute, life-threatening hypersensitivity
reaction
 Massive vasodilation
 Release of mediators
  Capillary permeability
Maldistribution of Blood Flow
Anaphylactic Shock (Contd)
 Clinical manifestations
 Anxiety, confusion, dizziness
 Tachycardia, tachypnea, hypotension
 Wheezing, stridor
 Sense of impending doom
 Chest pain
Maldistribution of Blood Flow
Anaphylactic Shock (Contd)
 Clinical manifestations
 Swelling of the lips and tongue, angioedema
 Wheezing, stridor
 Flushing, pruritus, urticaria
 Respiratory distress and circulatory failure
Maldistribution of Blood Flow
Septic Shock
 Sepsis: Systemic inflammatory response to
documented or suspected infection
 Severe sepsis = Sepsis + Organ dysfunction
Maldistribution of Blood Flow
Septic Shock (Contd)
 Septic shock = Presence of sepsis with
hypotension despite fluid resuscitation +
Presence of tissue perfusion abnormalities
Maldistribution of Blood Flow
Septic Shock (Contd)
 Mortality rates as high as 50%
 Primary causative organisms
 Gram-negative and gram-positive bacteria
 Endotoxin stimulates inflammatory response
Pathophysiology of Septic Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Maldistribution of Blood Flow
Septic Shock
 Clinical manifestations
  Coagulation and inflammation
  Fibrinolysis
 Formation of microthrombi
 Obstruction of microvasculature
 Hyperdynamic state: Increased CO and decreased
SVR
Maldistribution of Blood Flow
Septic Shock (Contd)
 Clinical manifestations
 Tachypnea/hyperventilation
 Temperature dysregulation
  Urine output
 Altered neurologic status
 GI dysfunction
 Respiratory failure is common
Stages of Shock
Initial Stage
 Usually not clinically apparent
 Metabolism changes from aerobic to
anaerobic
 Lactic acid accumulates and must be removed by
blood and broken down by liver
 Process requires unavailable O2
Stages of Shock
Compensatory Stage (Nonprogressive)
 Clinically apparent
 Neural
 Hormonal
 Biochemical compensatory mechanisms
 Attempts are aimed at overcoming
consequences of anaerobic metabolism and
maintaining homeostasis
Stages of Shock
Compensatory Stage (Nonprogressive)
 Baroreceptors in carotid and aortic bodies
activate SNS in response to  BP
 Vasoconstriction while blood to vital organs
maintained
  Blood to kidneys activates renin
angiotensin system
  Venous return to heart, CO, BP
Compensatory(Nonprogressive) Stage of
Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Stages of Shock
Compensatory Stage (Nonprogressive Contd)
 If perfusion deficit corrected, patient recovers
with no residual sequelae
 If deficit not corrected, patient enters
progressive stage
Stages of Shock
Progressive Stage (intermediate)
 Begins when compensatory mechanisms fail
 Aggressive interventions to prevent multiple
organ dysfunction syndrome
Progressive (intermediate)Stage of Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Stages of Shock
Progressive Stage (intermediate Contd)
 Hallmarks of  cellular perfusion and altered
capillary permeability:
 Leakage of protein into interstitial space
  Systemic interstitial edema
Stages of Shock
Progressive Stage (intermediate Contd)
 Anasarca (severe generalized edema)
 Fluid leakage affects solid organs and peripheral tissues
  Blood flow to pulmonary capillaries
Stages of Shock
Progressive Stage (intermediate Contd)
 Movement of fluid from pulmonary
vasculature to interstitium
 Pulmonary edema
 Bronchoconstriction
  Residual capacity
Stages of Shock
Progressive Stage (intermediate Contd)
 Fluid moves into alveoli
 Edema
 Decreased surfactant
 Worsening V/Q mismatch
 Tachypnea
 Crackles
 Increased work of breathing
Stages of Shock
Progressive Stage (intermediate Contd)
 CO begins to fall
 Decreased peripheral perfusion
 Hypotension
 Weak peripheral pulses
 Ischemia of distal extremities
Stages of Shock
Progressive Stage (intermediate Contd)
 Myocardial dysfunction results in
 Dysrhythmias
 Ischemia
 Myocardial infarction
 End result: Complete deterioration of cardiovascular
system
Stages of Shock
Progressive Stage (intermediate Contd)
 Mucosal barrier of GI system becomes
ischemic
 Ulcers
 Bleeding
 Risk of translocation of bacteria
 Decreased ability to absorb nutrients
Stages of Shock
Progressive Stage (intermediate Contd)
 Liver fails to metabolize drugs and wastes
 Jaundice
 Elevated enzymes
 Loss of immune function
 Risk for DIC and significant bleeding
Stages of Shock
Progressive Stage (intermediate Contd)
 Acute tubular necrosis/acute renal failure
Stages of Shock
Refractory Stage (Irreversible)
 Exacerbation of anaerobic metabolism
 Accumulation of lactic acid
  Capillary permeability
Stages of Shock
Refractory Stage
 Profound hypotension and hypoxemia
 Tachycardia worsens
 Decreased coronary blood flow
 Cerebral ischemia
Stages of Shock
Refractory Stage (Contd)
 Failure of one organ system affects others
 Recovery unlikely
Diagnostic Studies
 Through history and physical examination
 No single study to determine shock
 Blood studies
 Elevation of lactate
 Base deficit
 12-lead ECG
 Chest x-ray
 Hemodynamic monitoring
Collaborative Care
 Successful management includes
 Identification of patients at risk for shock
 Integration of the patients history, physical
examination, and clinical findings to establish a
diagnosis
Collaborative Care (Contd)
 Successful management includes
 Interventions to control or eliminate the cause of
the decreased perfusion
 Protection of target and distal organs from
dysfunction
 Provision of multisystem supportive care
Collaborative Care (Contd)
 General management strategies
 Ensure patent airway
 Maximize oxygen delivery
Collaborative Care (Contd)
 Cornerstone of therapy for septic,
hypovolemic, and anaphylactic shock =
volume expansion
 Isotonic crystalloids (e.g., normal saline) for initial
resuscitation of shock
Collaborative Care (Contd)
 Volume expansion
 If the patient does not respond to 2 to 3 L of
crystalloids, blood administration and central
venous monitoring may be instituted
 Complications of fluid resuscitation
 Hypothermia
 Coagulopathy
Collaborative Care (Contd)
 Primary goal of drug therapy = correction of
decreased tissue perfusion
 Vasopressor drugs (e.g., epinephrine)
 Achieve/maintain MAP >60 to 65 mm Hg
 Reserved for patients unresponsive to other therapies
Collaborative Care (Contd)
 Primary goal of drug therapy = correction of
decreased tissue perfusion
 Vasodilator therapy (e.g., nitroglycerin
[cardiogenic shock], nitroprusside [noncardiogenic
shock])
 Achieve/maintain MAP >60 to 65 mm Hg
Collaborative Care (Contd)
 Nutrition is vital to decreasing morbidity from
shock
 Initiate enteral nutrition within the first 24 hours
Collaborative Care (Contd)
 Nutrition is vital to decreasing morbidity from
shock
 Initiate parenteral nutrition if enteral feedings
contraindicated or fail to meet at least 80% of the
caloric requirements
 Monitor protein, nitrogen balance, BUN, glucose,
electrolytes
Collaborative Care
Cardiogenic Shock
 Restore blood flow to the myocardium by
restoring the balance between O2 supply and
demand
 Thrombolytic therapy
 Angioplasty with stenting
 Emergency revascularization
 Valve replacement
Collaborative Care
Cardiogenic Shock (Contd)
 Hemodynamic monitoring
 Drug therapy (e.g., diuretics to reduce
preload)
 Circulatory assist devices (e.g., intra-aortic
balloon pump, ventricular assist device)
Collaborative Care
Hypovolemic Shock
 Management focuses on stopping the loss of
fluid and restoring the circulating volume
 Fluid replacement is calculated using a 3:1
rule (3 ml of isotonic crystalloid for every 1 ml
of estimated blood loss)
Collaborative Care
Septic Shock
 Fluid replacement (e.g., 6 to 10 L of isotonic
crystalloids and 2 to 4 L of colloids) to restore
perfusion
 Hemodynamic monitoring
 Vasopressor drug therapy; vasopressin for
patients refractory to vasopressor therapy
Collaborative Care
Septic Shock (Contd)
 Intravenous corticosteroids for patients who
require vasopressor therapy, despite fluid
resuscitation, to maintain adequate BP
Collaborative Care
Septic Shock (Contd)
 Antibiotics after obtaining cultures
(e.g., blood, wound exudate, urine, stool,
sputum)
 Drotrecogin alfa (Xigris)
 Major side effect: Bleeding
Collaborative Care
Septic Shock (Contd)
 Glucose levels <150 mg/dl
 Stress ulcer prophylaxis with histamine (H2)-
receptor blockers
 Deep vein thrombosis prophylaxis with low-
dose unfractionated heparin or low-
molecular-weight heparin
Collaborative Care
Neurogenic Shock
 In spinal cord injury: Spinal stability
 Treatment of the hypotension and bradycardia
with vasopressors and atropine
 Fluids used cautiously as hypotension is generally
not related to fluid loss
 Monitor for hypothermia
Collaborative Care
Anaphylactic Shock
 Epinephrine, diphenhydramine
 Maintaining a patent airway
 Nebulized bronchodilators
 Endotracheal intubation or cricothyroidotomy may be
necessary
Collaborative Care
Anaphylactic Shock (Contd)
 Aggressive fluid replacement
 Intravenous corticosteroids if significant
hypotension persists after 1 to 2 hours of
aggressive therapy
Nursing Assessment (Contd)
 ABCs: Airway, breathing, and circulation
 Focused assessment of tissue perfusion
 Vital signs
 Peripheral pulses
 Level of consciousness
 Capillary refill
 Skin (e.g., temperature, color, moisture)
 Urine output
Nursing Assessment (Contd)
 Brief history
 Events leading to shock
 Onset and duration of symptoms
 Details of care received before hospitalization
 Allergies
 Vaccinations
Nursing Diagnoses
 Ineffective tissue perfusion: Renal, cerebral,
cardiopulmonary, gastrointestinal, hepatic,
and peripheral
 Fear
 Potential complication: Organ
ischemia/dysfunction
Planning
 Goals for patient
 Assurance of adequate tissue perfusion
 Restoration of normal or baseline BP
 Return/recovery of organ function
 Avoidance of complications from prolonged states
of hypoperfusion
Nursing Implementation
 Health Promotion
 Identify patients at risk (e.g., elderly patients,
those with debilitating illnesses or who are
immunocompromised, surgical or accidental
trauma patients)
Nursing Implementation (Contd)
 Health Promotion
 Planning to prevent shock
(e.g., monitoring fluid balance to prevent
hypovolemic shock, maintenance of handwashing
to prevent spread of infection)
Nursing Implementation (Contd)
 Acute Interventions
 Monitor the patients ongoing physical and
emotional status to detect subtle changes in the
patients condition
 Plan and implement nursing interventions and
therapy
Nursing Implementation (Contd)
 Acute Interventions
 Evaluate the patients response to therapy
 Provide emotional support to the patient and
family
 Collaborate with other members of the health
team when warranted
Nursing Implementation (Contd)
 Neurologic status: Orientation and level of
consciousness
 Cardiac status
 Continuous ECG
 VS, capillary refill
 Hemodynamic parameters: central venous
pressure, PA pressures, CO, PAWP
 Heart sounds: Murmurs, S3, S4
Nursing Implementation (Contd)
 Respiratory status
 Respiratory rate and rhythm
 Breath sounds
 Continuous pulse oximetry
 Arterial blood gases
 Most patients will be intubated and mechanically
ventilated
Nursing Implementation (Contd)
 Urine output
 Tympanic or pulmonary arterial temperature
 Skin: Temperature, pallor, flushing, cyanosis,
diaphoresis, piloerection
 Bowel sounds
Nursing Implementation (Contd)
 Nasogastric drainage/stools for occult blood
 I&O, fluid and electrolyte balance
 Oral care/hygiene based on O2 requirements
 Passive/active range of motion
Nursing Implementation (Contd)
 Assess level of anxiety and fear
 Medication PRN
 Talk to patient
 Visit from clergy
 Family involvement
 Comfort measures
 Privacy
 Call light within reach
Evaluation
 Normal or baseline, ECG, BP, CVP, and PAWP
 Normal temperature
 Warm, dry skin
 Urinary output >0.5 ml/kg/hr
 Normal RR and SaO2 90%
 Verbalization of fears, anxiety
THANK YOU VERY MUCH FOR
YOUR ATTENTION.

More Related Content

Similar to Shock Presentation Definition, etiology, types and management (20)

Approach to paediatric shock dr jason
Approach to paediatric shock dr jasonApproach to paediatric shock dr jason
Approach to paediatric shock dr jason
Jason Dsouza
Shock
ShockShock
Shock
Bone Cracker Eliz
2. Hypovolemic, Septic and Cardiogenic Shock.pptx
2. Hypovolemic, Septic and Cardiogenic Shock.pptx2. Hypovolemic, Septic and Cardiogenic Shock.pptx
2. Hypovolemic, Septic and Cardiogenic Shock.pptx
farihinizhar
SHOCK. In medicine and health for students pptx
SHOCK. In medicine and health for students pptxSHOCK. In medicine and health for students pptx
SHOCK. In medicine and health for students pptx
ANDREWODHIAMBO12
Management of Shock
Management of ShockManagement of Shock
Management of Shock
Khagendra Shrestha
Shock
Shock Shock
Shock
Janam Shrestha
Shock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptxShock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptx
ssuser2b0ef3
Shock sendiri
Shock sendiriShock sendiri
Shock sendiri
Khairul Anam
Clinical classification of Shock and management.pptx
Clinical classification of Shock and management.pptxClinical classification of Shock and management.pptx
Clinical classification of Shock and management.pptx
Scarter96
SEMINAR SURGERY approach for shock and its mgt
SEMINAR SURGERY approach for shock and its mgtSEMINAR SURGERY approach for shock and its mgt
SEMINAR SURGERY approach for shock and its mgt
BIRHANETESFAY1
Shock in Children . management of shock in children
Shock in Children . management of shock in childrenShock in Children . management of shock in children
Shock in Children . management of shock in children
Sandeep121900
Shock type recondition and therapy
Shock type recondition and therapy Shock type recondition and therapy
Shock type recondition and therapy
C L GUPTA EYE INSTITUTE MORADABAD UTTER PRADESH
Shock for BS Medical technologist
Shock for BS Medical technologistShock for BS Medical technologist
Shock for BS Medical technologist
Nadeem Khan
SHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosisSHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosis
Sdt Liin
SHOCK IN CHILDREN.pptxwsdffffgggggghhhhhhhuh
SHOCK IN CHILDREN.pptxwsdffffgggggghhhhhhhuhSHOCK IN CHILDREN.pptxwsdffffgggggghhhhhhhuh
SHOCK IN CHILDREN.pptxwsdffffgggggghhhhhhhuh
abd12medy
Adolescent growth and development understand hiv an aids/stis
Adolescent growth and development understand hiv an aids/stisAdolescent growth and development understand hiv an aids/stis
Adolescent growth and development understand hiv an aids/stis
MuniraMkamba
hypovolemic shock.pdf
hypovolemic shock.pdfhypovolemic shock.pdf
hypovolemic shock.pdf
karna ram choudhary
pediatric Shock management seminar ppt slide
pediatric Shock management seminar ppt slidepediatric Shock management seminar ppt slide
pediatric Shock management seminar ppt slide
jerusalemabated
Heart failure / cardiac failure
Heart failure / cardiac failureHeart failure / cardiac failure
Heart failure / cardiac failure
Fuad Farooq
SHOCK Assignment.pptx
SHOCK Assignment.pptxSHOCK Assignment.pptx
SHOCK Assignment.pptx
Leonard Otieno
Approach to paediatric shock dr jason
Approach to paediatric shock dr jasonApproach to paediatric shock dr jason
Approach to paediatric shock dr jason
Jason Dsouza
2. Hypovolemic, Septic and Cardiogenic Shock.pptx
2. Hypovolemic, Septic and Cardiogenic Shock.pptx2. Hypovolemic, Septic and Cardiogenic Shock.pptx
2. Hypovolemic, Septic and Cardiogenic Shock.pptx
farihinizhar
SHOCK. In medicine and health for students pptx
SHOCK. In medicine and health for students pptxSHOCK. In medicine and health for students pptx
SHOCK. In medicine and health for students pptx
ANDREWODHIAMBO12
Shock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptxShock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptx
ssuser2b0ef3
Clinical classification of Shock and management.pptx
Clinical classification of Shock and management.pptxClinical classification of Shock and management.pptx
Clinical classification of Shock and management.pptx
Scarter96
SEMINAR SURGERY approach for shock and its mgt
SEMINAR SURGERY approach for shock and its mgtSEMINAR SURGERY approach for shock and its mgt
SEMINAR SURGERY approach for shock and its mgt
BIRHANETESFAY1
Shock in Children . management of shock in children
Shock in Children . management of shock in childrenShock in Children . management of shock in children
Shock in Children . management of shock in children
Sandeep121900
Shock for BS Medical technologist
Shock for BS Medical technologistShock for BS Medical technologist
Shock for BS Medical technologist
Nadeem Khan
SHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosisSHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosis
Sdt Liin
SHOCK IN CHILDREN.pptxwsdffffgggggghhhhhhhuh
SHOCK IN CHILDREN.pptxwsdffffgggggghhhhhhhuhSHOCK IN CHILDREN.pptxwsdffffgggggghhhhhhhuh
SHOCK IN CHILDREN.pptxwsdffffgggggghhhhhhhuh
abd12medy
Adolescent growth and development understand hiv an aids/stis
Adolescent growth and development understand hiv an aids/stisAdolescent growth and development understand hiv an aids/stis
Adolescent growth and development understand hiv an aids/stis
MuniraMkamba
pediatric Shock management seminar ppt slide
pediatric Shock management seminar ppt slidepediatric Shock management seminar ppt slide
pediatric Shock management seminar ppt slide
jerusalemabated
Heart failure / cardiac failure
Heart failure / cardiac failureHeart failure / cardiac failure
Heart failure / cardiac failure
Fuad Farooq
SHOCK Assignment.pptx
SHOCK Assignment.pptxSHOCK Assignment.pptx
SHOCK Assignment.pptx
Leonard Otieno

Recently uploaded (20)

Performance of molecular and serologic tests for the diagnosis of scrub typhus
Performance of molecular and serologic tests for the diagnosis of scrub typhusPerformance of molecular and serologic tests for the diagnosis of scrub typhus
Performance of molecular and serologic tests for the diagnosis of scrub typhus
SmitaDeshkar
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
reproductive disorder, etiology ,pathobiology ,clinical sign, treatment and p...
reproductive disorder, etiology ,pathobiology ,clinical sign, treatment and p...reproductive disorder, etiology ,pathobiology ,clinical sign, treatment and p...
reproductive disorder, etiology ,pathobiology ,clinical sign, treatment and p...
YIHENEW CHALLIE LIYEW
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptxOBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
Selvaraj Balasubramani
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptxPULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
arunmbbs7
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025
Badalona Serveis Assistencials
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdfMLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
Eswatini Medical Christian University - EMCU / Southern Nazarene University - SANU
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
Biography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo GiordanoBiography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo Giordano
Dr. Vincenzo Giordano
surgical notes for new houseman.very good explanation
surgical notes for new houseman.very good explanationsurgical notes for new houseman.very good explanation
surgical notes for new houseman.very good explanation
musaAlRashid
Endocarditis.pptx
Endocarditis.pptxEndocarditis.pptx
Endocarditis.pptx
Nandish Sannaiah
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
PVI, PeerView Institute for Medical Education
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONSRESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
Shimla
MALE REPRODUCTIVE PHYSIOLOGY up load.pptx
MALE REPRODUCTIVE PHYSIOLOGY up load.pptxMALE REPRODUCTIVE PHYSIOLOGY up load.pptx
MALE REPRODUCTIVE PHYSIOLOGY up load.pptx
YIHENEW CHALLIE LIYEW
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
Module 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplaceModule 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplace
AbbieNunez
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
Performance of molecular and serologic tests for the diagnosis of scrub typhus
Performance of molecular and serologic tests for the diagnosis of scrub typhusPerformance of molecular and serologic tests for the diagnosis of scrub typhus
Performance of molecular and serologic tests for the diagnosis of scrub typhus
SmitaDeshkar
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
reproductive disorder, etiology ,pathobiology ,clinical sign, treatment and p...
reproductive disorder, etiology ,pathobiology ,clinical sign, treatment and p...reproductive disorder, etiology ,pathobiology ,clinical sign, treatment and p...
reproductive disorder, etiology ,pathobiology ,clinical sign, treatment and p...
YIHENEW CHALLIE LIYEW
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptxOBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
Selvaraj Balasubramani
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptxPULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
arunmbbs7
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
Biography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo GiordanoBiography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo Giordano
Dr. Vincenzo Giordano
surgical notes for new houseman.very good explanation
surgical notes for new houseman.very good explanationsurgical notes for new houseman.very good explanation
surgical notes for new houseman.very good explanation
musaAlRashid
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONSRESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
Shimla
MALE REPRODUCTIVE PHYSIOLOGY up load.pptx
MALE REPRODUCTIVE PHYSIOLOGY up load.pptxMALE REPRODUCTIVE PHYSIOLOGY up load.pptx
MALE REPRODUCTIVE PHYSIOLOGY up load.pptx
YIHENEW CHALLIE LIYEW
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
Module 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplaceModule 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplace
AbbieNunez
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla

Shock Presentation Definition, etiology, types and management

  • 1. SHOCK MANAGEMENT PRESENTATION BY DR AMINU BELLO DIRECTOR SCHOOL OF NURSING KATSINA
  • 2. Shock Syndrome characterized by decreased tissue perfusion and impaired cellular metabolism Imbalance in supply/demand for O2 and nutrients
  • 3. Shock (Contd) Classification of shock Low blood flow Cardiogenic Hypovolemic Maldistribution of blood flow Septic Anaphylactic Neurogenic
  • 4. Low Blood Flow Carcinogenic Shock Definition Systolic or diastolic dysfunction Compromised cardiac output (CO)
  • 5. Low Blood Flow Cardiogenic Shock (Contd) Precipitating causes Myocardial infarction Cardiomyopathy Blunt cardiac injury Severe systemic or pulmonary hypertension Cardiac tamponade (Obstructive) Myocardial depression from metabolic problems
  • 7. Low Blood Flow Cardiogenic Shock Early manifestations Tachycardia Hypotension Narrowed pulse pressure Myocardial O2 consumption
  • 8. Low Blood Flow Cardiogenic Shock (Contd) Physical examination Tachypnea, pulmonary congestion Pallor; cool, clammy skin Decreased capillary refill time Anxiety, confusion, agitation in pulmonary artery wedge pressure Decreased renal perfusion and UO
  • 9. Low Blood Flow Hypovolemic Shock Absolute hypovolemia: Loss of intravascular fluid volume Hemorrhage GI loss (e.g., vomiting, diarrhea) Fistula drainage Diabetes insipidus Hyperglycemia Diuresis
  • 10. Low Blood Flow Hypovolemic Shock (Contd) Relative hypovolemia Results when fluid volume moves out of the vascular space into extravascular space (e.g., interstitial or intracavitary space) Termed third spacing
  • 11. Pathophysiology of Hypovolemic Shock Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
  • 12. Low Blood Flow Hypovolemic Shock Response to acute volume loss depends on Extent of injury or insult Age General state of health
  • 13. Low Blood Flow Hypovolemic Shock (Contd) Clinical manifestations Anxiety Tachypnea Increase in CO, heart rate Decrease in stroke volume, PAWP, UO If loss is >30%, blood volume is replaced
  • 14. Maldistribution of Blood Flow Neurogenic Shock Hemodynamic phenomenon that can occur within 30 minutes of a spinal cord injury at the fifth thoracic (T5) vertebra or above and can last up to 6 weeks Results in massive vasodilation leading to pooling of blood in vessels
  • 15. Pathophysiology of Neurogenic Shock Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
  • 16. Maldistribution of Blood Flow Neurogenic Shock (Contd) Clinical manifestations Hypotension Bradycardia Temperature dysregulation (resulting in heat loss) Dry skin Poikilothermia (taking on the temperature of the environment)
  • 17. Maldistribution of Blood Flow Anaphylactic Shock Acute, life-threatening hypersensitivity reaction Massive vasodilation Release of mediators Capillary permeability
  • 18. Maldistribution of Blood Flow Anaphylactic Shock (Contd) Clinical manifestations Anxiety, confusion, dizziness Tachycardia, tachypnea, hypotension Wheezing, stridor Sense of impending doom Chest pain
  • 19. Maldistribution of Blood Flow Anaphylactic Shock (Contd) Clinical manifestations Swelling of the lips and tongue, angioedema Wheezing, stridor Flushing, pruritus, urticaria Respiratory distress and circulatory failure
  • 20. Maldistribution of Blood Flow Septic Shock Sepsis: Systemic inflammatory response to documented or suspected infection Severe sepsis = Sepsis + Organ dysfunction
  • 21. Maldistribution of Blood Flow Septic Shock (Contd) Septic shock = Presence of sepsis with hypotension despite fluid resuscitation + Presence of tissue perfusion abnormalities
  • 22. Maldistribution of Blood Flow Septic Shock (Contd) Mortality rates as high as 50% Primary causative organisms Gram-negative and gram-positive bacteria Endotoxin stimulates inflammatory response
  • 23. Pathophysiology of Septic Shock Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
  • 24. Maldistribution of Blood Flow Septic Shock Clinical manifestations Coagulation and inflammation Fibrinolysis Formation of microthrombi Obstruction of microvasculature Hyperdynamic state: Increased CO and decreased SVR
  • 25. Maldistribution of Blood Flow Septic Shock (Contd) Clinical manifestations Tachypnea/hyperventilation Temperature dysregulation Urine output Altered neurologic status GI dysfunction Respiratory failure is common
  • 26. Stages of Shock Initial Stage Usually not clinically apparent Metabolism changes from aerobic to anaerobic Lactic acid accumulates and must be removed by blood and broken down by liver Process requires unavailable O2
  • 27. Stages of Shock Compensatory Stage (Nonprogressive) Clinically apparent Neural Hormonal Biochemical compensatory mechanisms Attempts are aimed at overcoming consequences of anaerobic metabolism and maintaining homeostasis
  • 28. Stages of Shock Compensatory Stage (Nonprogressive) Baroreceptors in carotid and aortic bodies activate SNS in response to BP Vasoconstriction while blood to vital organs maintained Blood to kidneys activates renin angiotensin system Venous return to heart, CO, BP
  • 29. Compensatory(Nonprogressive) Stage of Shock Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
  • 30. Stages of Shock Compensatory Stage (Nonprogressive Contd) If perfusion deficit corrected, patient recovers with no residual sequelae If deficit not corrected, patient enters progressive stage
  • 31. Stages of Shock Progressive Stage (intermediate) Begins when compensatory mechanisms fail Aggressive interventions to prevent multiple organ dysfunction syndrome
  • 32. Progressive (intermediate)Stage of Shock Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
  • 33. Stages of Shock Progressive Stage (intermediate Contd) Hallmarks of cellular perfusion and altered capillary permeability: Leakage of protein into interstitial space Systemic interstitial edema
  • 34. Stages of Shock Progressive Stage (intermediate Contd) Anasarca (severe generalized edema) Fluid leakage affects solid organs and peripheral tissues Blood flow to pulmonary capillaries
  • 35. Stages of Shock Progressive Stage (intermediate Contd) Movement of fluid from pulmonary vasculature to interstitium Pulmonary edema Bronchoconstriction Residual capacity
  • 36. Stages of Shock Progressive Stage (intermediate Contd) Fluid moves into alveoli Edema Decreased surfactant Worsening V/Q mismatch Tachypnea Crackles Increased work of breathing
  • 37. Stages of Shock Progressive Stage (intermediate Contd) CO begins to fall Decreased peripheral perfusion Hypotension Weak peripheral pulses Ischemia of distal extremities
  • 38. Stages of Shock Progressive Stage (intermediate Contd) Myocardial dysfunction results in Dysrhythmias Ischemia Myocardial infarction End result: Complete deterioration of cardiovascular system
  • 39. Stages of Shock Progressive Stage (intermediate Contd) Mucosal barrier of GI system becomes ischemic Ulcers Bleeding Risk of translocation of bacteria Decreased ability to absorb nutrients
  • 40. Stages of Shock Progressive Stage (intermediate Contd) Liver fails to metabolize drugs and wastes Jaundice Elevated enzymes Loss of immune function Risk for DIC and significant bleeding
  • 41. Stages of Shock Progressive Stage (intermediate Contd) Acute tubular necrosis/acute renal failure
  • 42. Stages of Shock Refractory Stage (Irreversible) Exacerbation of anaerobic metabolism Accumulation of lactic acid Capillary permeability
  • 43. Stages of Shock Refractory Stage Profound hypotension and hypoxemia Tachycardia worsens Decreased coronary blood flow Cerebral ischemia
  • 44. Stages of Shock Refractory Stage (Contd) Failure of one organ system affects others Recovery unlikely
  • 45. Diagnostic Studies Through history and physical examination No single study to determine shock Blood studies Elevation of lactate Base deficit 12-lead ECG Chest x-ray Hemodynamic monitoring
  • 46. Collaborative Care Successful management includes Identification of patients at risk for shock Integration of the patients history, physical examination, and clinical findings to establish a diagnosis
  • 47. Collaborative Care (Contd) Successful management includes Interventions to control or eliminate the cause of the decreased perfusion Protection of target and distal organs from dysfunction Provision of multisystem supportive care
  • 48. Collaborative Care (Contd) General management strategies Ensure patent airway Maximize oxygen delivery
  • 49. Collaborative Care (Contd) Cornerstone of therapy for septic, hypovolemic, and anaphylactic shock = volume expansion Isotonic crystalloids (e.g., normal saline) for initial resuscitation of shock
  • 50. Collaborative Care (Contd) Volume expansion If the patient does not respond to 2 to 3 L of crystalloids, blood administration and central venous monitoring may be instituted Complications of fluid resuscitation Hypothermia Coagulopathy
  • 51. Collaborative Care (Contd) Primary goal of drug therapy = correction of decreased tissue perfusion Vasopressor drugs (e.g., epinephrine) Achieve/maintain MAP >60 to 65 mm Hg Reserved for patients unresponsive to other therapies
  • 52. Collaborative Care (Contd) Primary goal of drug therapy = correction of decreased tissue perfusion Vasodilator therapy (e.g., nitroglycerin [cardiogenic shock], nitroprusside [noncardiogenic shock]) Achieve/maintain MAP >60 to 65 mm Hg
  • 53. Collaborative Care (Contd) Nutrition is vital to decreasing morbidity from shock Initiate enteral nutrition within the first 24 hours
  • 54. Collaborative Care (Contd) Nutrition is vital to decreasing morbidity from shock Initiate parenteral nutrition if enteral feedings contraindicated or fail to meet at least 80% of the caloric requirements Monitor protein, nitrogen balance, BUN, glucose, electrolytes
  • 55. Collaborative Care Cardiogenic Shock Restore blood flow to the myocardium by restoring the balance between O2 supply and demand Thrombolytic therapy Angioplasty with stenting Emergency revascularization Valve replacement
  • 56. Collaborative Care Cardiogenic Shock (Contd) Hemodynamic monitoring Drug therapy (e.g., diuretics to reduce preload) Circulatory assist devices (e.g., intra-aortic balloon pump, ventricular assist device)
  • 57. Collaborative Care Hypovolemic Shock Management focuses on stopping the loss of fluid and restoring the circulating volume Fluid replacement is calculated using a 3:1 rule (3 ml of isotonic crystalloid for every 1 ml of estimated blood loss)
  • 58. Collaborative Care Septic Shock Fluid replacement (e.g., 6 to 10 L of isotonic crystalloids and 2 to 4 L of colloids) to restore perfusion Hemodynamic monitoring Vasopressor drug therapy; vasopressin for patients refractory to vasopressor therapy
  • 59. Collaborative Care Septic Shock (Contd) Intravenous corticosteroids for patients who require vasopressor therapy, despite fluid resuscitation, to maintain adequate BP
  • 60. Collaborative Care Septic Shock (Contd) Antibiotics after obtaining cultures (e.g., blood, wound exudate, urine, stool, sputum) Drotrecogin alfa (Xigris) Major side effect: Bleeding
  • 61. Collaborative Care Septic Shock (Contd) Glucose levels <150 mg/dl Stress ulcer prophylaxis with histamine (H2)- receptor blockers Deep vein thrombosis prophylaxis with low- dose unfractionated heparin or low- molecular-weight heparin
  • 62. Collaborative Care Neurogenic Shock In spinal cord injury: Spinal stability Treatment of the hypotension and bradycardia with vasopressors and atropine Fluids used cautiously as hypotension is generally not related to fluid loss Monitor for hypothermia
  • 63. Collaborative Care Anaphylactic Shock Epinephrine, diphenhydramine Maintaining a patent airway Nebulized bronchodilators Endotracheal intubation or cricothyroidotomy may be necessary
  • 64. Collaborative Care Anaphylactic Shock (Contd) Aggressive fluid replacement Intravenous corticosteroids if significant hypotension persists after 1 to 2 hours of aggressive therapy
  • 65. Nursing Assessment (Contd) ABCs: Airway, breathing, and circulation Focused assessment of tissue perfusion Vital signs Peripheral pulses Level of consciousness Capillary refill Skin (e.g., temperature, color, moisture) Urine output
  • 66. Nursing Assessment (Contd) Brief history Events leading to shock Onset and duration of symptoms Details of care received before hospitalization Allergies Vaccinations
  • 67. Nursing Diagnoses Ineffective tissue perfusion: Renal, cerebral, cardiopulmonary, gastrointestinal, hepatic, and peripheral Fear Potential complication: Organ ischemia/dysfunction
  • 68. Planning Goals for patient Assurance of adequate tissue perfusion Restoration of normal or baseline BP Return/recovery of organ function Avoidance of complications from prolonged states of hypoperfusion
  • 69. Nursing Implementation Health Promotion Identify patients at risk (e.g., elderly patients, those with debilitating illnesses or who are immunocompromised, surgical or accidental trauma patients)
  • 70. Nursing Implementation (Contd) Health Promotion Planning to prevent shock (e.g., monitoring fluid balance to prevent hypovolemic shock, maintenance of handwashing to prevent spread of infection)
  • 71. Nursing Implementation (Contd) Acute Interventions Monitor the patients ongoing physical and emotional status to detect subtle changes in the patients condition Plan and implement nursing interventions and therapy
  • 72. Nursing Implementation (Contd) Acute Interventions Evaluate the patients response to therapy Provide emotional support to the patient and family Collaborate with other members of the health team when warranted
  • 73. Nursing Implementation (Contd) Neurologic status: Orientation and level of consciousness Cardiac status Continuous ECG VS, capillary refill Hemodynamic parameters: central venous pressure, PA pressures, CO, PAWP Heart sounds: Murmurs, S3, S4
  • 74. Nursing Implementation (Contd) Respiratory status Respiratory rate and rhythm Breath sounds Continuous pulse oximetry Arterial blood gases Most patients will be intubated and mechanically ventilated
  • 75. Nursing Implementation (Contd) Urine output Tympanic or pulmonary arterial temperature Skin: Temperature, pallor, flushing, cyanosis, diaphoresis, piloerection Bowel sounds
  • 76. Nursing Implementation (Contd) Nasogastric drainage/stools for occult blood I&O, fluid and electrolyte balance Oral care/hygiene based on O2 requirements Passive/active range of motion
  • 77. Nursing Implementation (Contd) Assess level of anxiety and fear Medication PRN Talk to patient Visit from clergy Family involvement Comfort measures Privacy Call light within reach
  • 78. Evaluation Normal or baseline, ECG, BP, CVP, and PAWP Normal temperature Warm, dry skin Urinary output >0.5 ml/kg/hr Normal RR and SaO2 90% Verbalization of fears, anxiety
  • 79. THANK YOU VERY MUCH FOR YOUR ATTENTION.